ArticleCancer immunology, immunotherapy : CII2022

Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer.

Marion Thibaudin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.